MAPRx Submits Comment Letter on H.R. 3
Earlier today, the MAPRx Coalition submitted feedback and comments on Title III of H.R. 3, the Lower Drug Costs Now Act of 2019, to the Chairs and Ranking Members of the House of Representatives’ Ways & Means, Energy & Commerce, and Education & Labor Committees.
The Coalition appreciates the House’s leadership in advancing policy to cap out-of-pocket costs for Medicare Part D beneficiaries. The Coalition’s comments focus on the elements of H.R. 3 that impact Medicare Part D, including protecting against unintended consequences on the experience of Part D beneficiaries that could result from the many other changes included in the legislation.